CEO Watcher

Top executives at Affirm Holdings (AFRM) are initiating large, pre-planned stock sales, which historically preceded a 90% decline for the stock. Similarly, significant unscheduled sales by insiders at M&T Bank (MTB) and Collegium Pharmaceuticals (COLL) suggest these stocks may have peaked after recent run-ups. Conversely, a director at Residio Technologies (REZI) with a history of generating 100%+ returns just made a $1 million purchase, signaling strong bullish conviction. Multiple executives at Coty Inc. (COTY), including the CEO and CFO, are also buying shares, indicating a potential bottom for the beaten-down stock. These insider actions suggest caution for high-flying tech stocks while highlighting potential turnaround plays in value-oriented names.

Consider buying Eastman Chemical (EMN), as a group of 10 insiders who historically only sell have collectively purchased over $1.8 million in stock following a 30% price decline. The CEO of Bramer Hotels and Resorts (BHR) made his largest-ever stock purchase, and his previous buys have a 100% one-year win rate with an average 28% return. Unprecedented insider buying at Triple Point Venture Group (TPBG), totaling 20 times more than any previous quarter, also signals strong conviction from leadership. Conversely, investors should be cautious with Datadog (DDOG) after a director sold nearly $100 million in stock, his largest sale ever. Similarly, avoid WESCO International (WCC) where five insiders, led by a CEO with a strong track record of timing sales, are selling heavily near the stock's peak.

Executives at Triple Point Venture (TPVG) are continuing a multi-million dollar buying spree, signaling strong conviction that the stock remains undervalued. Similarly, top executives at The Cooper Companies (COO) are making their first-ever share purchases after a 30% price decline, a historically bullish indicator for the company. Conversely, insiders at Liquidia (LQDA) are selling shares at a record pace following its recent 60% price surge, suggesting the stock may now be overvalued. A Lending Club (LC) executive with a perfect track record of selling at the peak has also initiated a new plan to sell shares, a notable bearish signal. These insider actions suggest potential opportunity in TPVG and COO, while urging caution for LQDA and LC.

Unprecedented insider buying at Eastman Chemical (EMN) and Eastern Bank Shares (EBC) signals strong bullish conviction from management after recent price drops. Eleven insiders at EMN and five at EBC made rare, coordinated purchases, suggesting they believe their stocks are significantly undervalued. Conversely, insiders at Wheels Up (UP) are selling after a 100% price increase, with key sellers historically timing sales before average stock drops of 25-50%. The former CEO of Snowflake (SNOW) also made his second-largest sale ever, a pattern that has previously led to poor stock performance over the following six to nine months. Lastly, the CEO of Enact Holdings (ACT) made his first-ever sale, a bearish indicator given his strong track record of timing trades.

Consider the cannabis deregulation theme, where insider buying in stocks like Tilray (TLRY) preceded a significant rally. A potentially lower-risk strategy involves buying shares when insiders do just before an earnings report, as seen with Resideo Technologies (REZI). Keep the drone and counter-drone sector on your watchlist as a developing theme with potential government backing. For high-risk, high-reward opportunities, consider buying biotech stocks before a major catalyst like clinical trial results and selling immediately after the news is released. Always remember to take profits, as even winning trades with strong insider signals can reverse course.

Consider buying TriplePoint Venture Growth (TPVG), where the CEO and CIO just made their largest-ever monthly stock purchase, totaling nearly $5 million. Infinity Natural Resources (INFI) also presents a strong buy signal, with the CEO making a first-ever purchase and a director making their largest buy after a 30% stock decline. Conversely, widespread insider selling at ANI Pharmaceuticals (ANIP), totaling over $35 million from 13 executives, signals a potential top after its recent 60% rally. Caution is also warranted for Skye Bioscience (SKYE), as a major owner with a history of successful timing sold a large position after the stock's recent surge. These insider actions suggest potential near-term upside in TPVG and INFI, while indicating significant risk in ANIP and SKYE.

Following a 30% stock decline, eight insiders at Eastman Chemical (EMN) collectively purchased $1.8 million in stock, marking the first insider buys since 2018. The CEO of Braemar Hotels & Resorts (BHR) made their largest-ever purchase, a signal that has historically preceded an average 16% return over the next three months. Conversely, insiders at Powell Industries (POWL) are selling significantly, with one executive's sales historically being followed by a 30% stock decline over the subsequent three months. A first-ever sale by a POWL Vice President and a record sale by the Managing Director amplify this bearish signal. Lastly, five insiders at Wesco International (WCC) sold $17 million after a 30% rally, suggesting a belief that the stock is now overvalued.

Consider a short-term trade in LKQ Corporation (LKQ), as the CEO's largest-ever purchase follows a 20% price decline, a pattern that has historically led to modest bounces. Insiders at Credit Acceptance Corp (CACC) are signaling a potential top, with the COO's largest sale ever historically preceding an average 17% stock decline within three months. Similarly, a director at Vertiv Holdings (VRT) sold nearly $13 million, and their previous sale was followed by a 30% drop, suggesting significant downside risk. Heavy insider selling at Power Solutions International (PSIX), totaling over $86 million after a 330% price surge, strongly indicates that insiders are taking profits. Conversely, widespread and aggressive insider buying at the recently IPO'd Avidia Bancorp signals strong internal confidence in the stock's value.

Based on significant insider trading activity, several key investment opportunities have emerged. Top executives at TriplePoint Venture Group and Hilltop Holdings are making their largest-ever stock purchases, signaling strong conviction in their companies' near-term performance. Insiders at Advanced Flower Capital are also buying heavily after a 50% price decline, suggesting they believe the stock is undervalued. Conversely, insiders at Wilding Group are selling shares at an accelerated rate after a massive 250% run-up, indicating the stock may have peaked. A director at Rockwell Automation with a history of selling at market tops also made a large, unscheduled sale, which could be a warning sign for investors.

Consider buying Western Union (WU) and Bakkt Holdings (BKKT), as both CEOs made their first-ever, multi-million dollar purchases after significant price declines, signaling strong confidence. The CEO of WU bought $1.5 million after the stock fell over 20% in the last year, while the BKKT CEO purchased $1.5 million after the stock plummeted over 50% last month. Conversely, an insider at Ivanhoe Electric (IE) sold stock and willingly forfeited a 50% profit to do so, a powerful signal that its recent rally may reverse. Caution is also advised for AIE Inc. (AEYE), where a director with a perfect selling record just sold shares, historically preceding an average stock drop of nearly 60%. Finally, the CEO of Johnson & Johnson (JNJ) sold a massive $22.5 million at an all-time high, suggesting top leadership believes the stock is fully valued.

A director made their first-ever open market purchase of Intellia Therapeutics (NTLA) for $1 million, signaling strong conviction after a recent price drop. This same director's only other purchase was timing the 2019 bottom in AbbVie (ABBV), which has since returned over 275%. On the bearish side, insiders at A&I Pharmaceuticals sold over $35 million worth of stock in a single month after a significant run-up. This record-breaking selling volume from twelve different insiders suggests a shared belief that the stock may be overvalued. Similarly, a key insider at SKYE Bioscience (SKYE) sold a large position, whose only prior sale preceded a 40% drop in the stock.

The Chairman of Hilltop Holdings (HTH) made his first-ever open market stock purchases, buying nearly $1 million worth, signaling extreme confidence. A director at Macrogenics (MGNX) also showed conviction by buying shares after a 50% stock decline; this director's last purchase preceded a 100% gain in three months. Conversely, consider avoiding Radnet (RDNT), as its CIO made his largest sale ever, and the stock previously fell 30% within three months of his last sale. Another potential opportunity is Carlisle Secured Lending (CSL), where the CFO's purchases have historically been followed by an average 30% gain over the next three months. These significant insider actions point to potential near-term opportunities in HTH, MGNX, and CSL, while suggesting caution with RDNT.

A major institutional investor's $600 million purchase of Madrigal Pharmaceuticals (MDGL) signals strong long-term confidence from a historically successful firm. Consider Triplepoint Venture Growth (TPVG), where the CEO's recent large buy follows a pattern that previously led to a 25% stock gain in three months. Conversely, a director's massive $40 million sale of Lifestance Health (LFST) is a significant bearish signal, as their past sales have preceded an average 25% drop. Significant insider selling at Humasite (HUMA) and General Dynamics (GD) also suggests insiders believe these stocks may have peaked. These actions present potential buying opportunities in MDGL and TPVG, while signaling caution for LFST, HUMA, and GD.

A director at Hallador Energy (HNRG) made their largest-ever stock purchase; historically, the stock has gained an average of 44% within three months following their buys. The CEO of Energy Focus (EFOI) also showed high conviction with a significant purchase that increased their personal holdings by over 13%. Conversely, investors should be cautious with Carpenter Technology (CRS) and Darling Ingredients (DAR), as both stocks have historically dropped 7-8% after recent large CEO sales. The CFO of Robinhood (HOOD) made their largest-ever unscheduled sale after a 65% run-up, signaling a potential peak for the stock. Finally, a cluster of insiders at Cipher Mining (CIFR) are selling into its recent 22% rally, suggesting the move may be overextended.

Multiple insiders at Sell & Needs Corporation are buying shares after a recent 25% drop, signaling a strong belief that the stock is undervalued. The CEO of Luma Technologies also made a significant purchase, and their past buys have historically averaged a 53% return within three months. Conversely, a very strong bearish signal is emerging at Telephone and Data Systems (TDS), where eight insiders have recently sold stock in a cluster. The co-executive chairmen of Zillow Group (Z, ZG) also made rare, unscheduled sales totaling $51 million, suggesting they believe the stock is overvalued. Lastly, an executive at Avis Budget Group (CAR) sold $1.57 million in stock after a 45% rally, and their past sales have preceded an average 21% decline.

Consider bullish positions in Bausch Health (BHC) following a record-breaking purchase by a major investor, and in Eli Lilly (LLY), Lumen (LUMN), and Valvoline (VVV) due to significant insider buying from top executives. The Valvoline (VVV) CFO's purchase is particularly notable as it was their first-ever open market buy, increasing personal holdings by 2,500%. Conversely, exercise caution with Wayfair (W) and Patrick Industries (PATK), where founders and multiple executives made their largest-ever unscheduled sales after major stock run-ups. A major institutional investor also made its largest sale ever in Klaviyo (KVYO), signaling potential concerns about the company's valuation. These actions suggest insiders see further upside in the former group and are taking profits in the latter.

Significant insider selling has been a strong bearish indicator since 2021, often preceding stock underperformance for the next 1 to 12 months. A current example is Hims & Hers Health (HIMS), which could face pressure due to a large CEO sale combined with slowing business growth. Conversely, insider buying is most effective when it aligns with a positive trend for the entire sector. For instance, insider buying at Tilray Brands (TLRY) preceded a major rally, supported by a bullish outlook for the cannabis industry. This same strategy proved successful for Kratos Defense & Security Solutions (KTOS), where CEO buying combined with a favorable view of the defense industry led to strong gains.

Following significant insider buying, UnitedHealthcare (UNH) still trades below the price where insiders and Berkshire Hathaway recently established positions. Bausch Health (BHC) is showing exceptional conviction after a key insider made a massive follow-on purchase of over $310 million. The CEO of biotech firm Curis, Inc. (CRIS) made his first-ever stock purchase ahead of potential clinical trial results expected by the end of the year. Similarly, insiders at Shift4 Payments (FOUR) and Xponential Fitness (XPOF) made their largest-ever purchases after price drops, signaling strong belief in a recovery. Conversely, multiple unscheduled insider sales at Hims & Hers Health (HIMS), including the CEO's largest ever, serve as a major red flag.